Co-Diagnostics, Inc. Initiates Clinical Evaluations for its At-Home and Point-of-Care Co-Dx PCR
Co-Diagnostics, Inc.a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced that it has commenced clinical evaluations for its at-home and point-of-care Co-Dx PCR